Sahajanand Medical Technologies IPO entered Day 2 on October 16, 2026, with a 12% GMP and 34% subscription on Day 1. The Rs 475.48-crore of...

Sahajanand Medical Technologies IPO opened for subscription on October 15, 2026, aiming to raise Rs 475.48 crore through an entirely offer-...

Biocon announced a settlement with Genentech over its biosimilar, Pebrilzo, of the cancer drug Perjeta. The agreement allows Biocon to laun...

Biocon has finalized a global settlement and license agreement with Genentech for its drug Pebrilzo. This agreement addresses all ongoing l...

The Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...

Pope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise...

Zydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...

An expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...

The Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...

The Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning wh...

Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...

The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...

The Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...

Abhay Soi, chairman of Max Healthcare, commented on scrutiny regarding hospital pricing in India. He stated that hospitals should be evalua...

The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...

The Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...

Novartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...